ASEP Medical Holdings Inc.
ASEP
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.95% | -36.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.95% | -36.09% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -0.95% | -36.09% | |||
| SG&A Expenses | 28.62% | -47.70% | |||
| Depreciation & Amortization | -2.05% | -41.54% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.38% | -52.33% | |||
| Operating Income | -29.11% | 55.01% | |||
| Income Before Tax | -149.43% | 94.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -131.39% | 94.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 234.75% | -99.15% | |||
| Net Income | -123.97% | 89.98% | |||
| EBIT | -29.11% | 55.01% | |||
| EBITDA | -45.60% | 59.90% | |||
| EPS Basic | -70.06% | 89.95% | |||
| Normalized Basic EPS | 19.12% | -111.55% | |||
| EPS Diluted | -70.06% | 89.95% | |||
| Normalized Diluted EPS | 19.12% | -111.55% | |||
| Average Basic Shares Outstanding | 31.46% | -0.02% | |||
| Average Diluted Shares Outstanding | 31.46% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||